Initial Management of Mild Gluteal Enthesopathy
NSAIDs are the first-line treatment for mild gluteal enthesopathy without tears or trochanteric bursal fluid collection. 1, 2, 3
Treatment Algorithm
First-Line Treatment:
- NSAIDs: Begin with oral NSAIDs for 2-4 weeks
If Inadequate Response After 2-4 Weeks:
Physical Therapy and Exercise:
- Progressive strengthening exercises focusing on hip abductors
- Stretching of the iliotibial band and hip flexors
- Avoidance of activities that compress the greater trochanter 4
Consider Local Interventions:
- Corticosteroid injection into the affected area if pain persists
- Evidence shows short-term efficacy (up to 12 weeks) for pain relief 5
Important Considerations
NSAID Safety:
- Monitor for gastrointestinal side effects (abdominal pain, heartburn)
- Use caution in patients with:
- Consider gastroprotection with proton pump inhibitors in high-risk patients 1
When to Consider Advanced Interventions:
If conservative management fails after 3-6 months:
- Platelet-rich plasma (PRP) injections may be superior to corticosteroid injections for longer-term outcomes 6
- Focused shockwave therapy shows promising long-term results 5
- Surgical intervention only if conservative measures fail and significant functional impairment persists 7, 8
Monitoring and Follow-up
- Reassess after 2-4 weeks of NSAID therapy
- If symptoms persist, progress to physical therapy while continuing NSAIDs as needed
- Evaluate for improvement in pain with activity, ability to bear weight, and functional capacity
Pitfalls to Avoid
- Prolonged NSAID use without reassessment
- Failure to implement appropriate activity modification
- Premature progression to invasive interventions before adequate trial of conservative management
- Overlooking the importance of physical therapy and rehabilitation in the treatment plan
The most recent evidence suggests that a structured approach beginning with NSAIDs, followed by physical therapy and education, provides the best outcomes for patients with mild gluteal enthesopathy 5.